Metabolomics in sepsis-associated acute kidney injury research
Croatian veterinary journal · 15.07.2026 · 57 (4) · 311-323
DOI: 10.46419/cvj.57.4.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Croatian veterinary journal, online erschienen am 15.07.2026. Verfasst von Dora Ivšić Škoda und 6 weiteren Autor:innen.
Themen: Sepsis
Abstract (Originalsprache)
Metabolomics is a scientific discipline focused on the analysis of metabolites in biological samples with the aim of understanding physiological and pathological processes. The development of analytical technologies, such as mass spectrometry and nuclear magnetic resonance, has enabled advances in untargeted and targeted metabolomic analysis. In untargeted analysis, a broad spectrum of metabolites is analysed without prior assumptions, whereas targeted analysis focuses on the quantification of known molecules. Biological samples such as serum, plasma and urine are most commonly used, with the choice depending on the clinical context and the nature of the disease. Despite its potential, metabolomics faces challenges such as technical complexity, biological variability, lack of standardisation, and the need for advanced statistical methods. However, in the last decade, it has been used extensively in the study of sepsis and associated acute kidney injury, a condition with high mortality and limited therapeutic options. In this review, we present metabolomics, the challenges it faces, and the current state of research concerning sepsis-associated acute kidney injury (SA-AKI). Metabolomic studies of SA-AKI have identified potential key biological changes, including enhanced inflammatory signalling, oxidative stress, osmolyte disturbances, and cellular metabolic dysfunction. Although individual metabolites have been recognised as potential diagnostic markers, none can fully capture the complex metabolic changes characteristic of SA-AKI. In the future, the integration of metabolomics with other "omics" and advanced analytical approaches could advance early disease detection, the understanding of pathophysiology, and the development of personalised therapies.
Zitieren
APA
Škoda, D. I., Maslov, D. R., Kuleš, J., Benko, V., Đurić, V., Rafaj, R. B., & Mrljak, V. (2026). Metabolomics in sepsis-associated acute kidney injury research. Croatian veterinary journal, 57(4), 311-323. https://doi.org/10.46419/cvj.57.4.3
Vancouver
Škoda DI, Maslov DR, Kuleš J, Benko V, Đurić V, Rafaj RB, et al. Metabolomics in sepsis-associated acute kidney injury research. Croatian veterinary journal. 2026;57(4):311-323. doi:10.46419/cvj.57.4.3
BibTeX
@article{koda2026,
author = {Škoda, Dora Ivšić and Maslov, Dina Rešetar and Kuleš, Josipa and Benko, Valerija and Đurić, Vlasta and Rafaj, Renata Barić and Mrljak, Vladimir},
title = {Metabolomics in sepsis-associated acute kidney injury research},
journal = {Croatian veterinary journal},
year = {2026},
volume = {57},
number = {4},
pages = {311--323},
doi = {10.46419/cvj.57.4.3}
}
EUVIMED